This webinar's emphasis on CLIA quality standards and the integration of Integri-sense Technology within RAPIDPoint® 500e System seeks to illuminate the path toward enhanced quality management at the ...

The infectious disease diagnostic company MeMed is taking a big step toward a larger market of point-of-care settings, courtesy of a new FDA green light for its test that distinguishes between viral ...

In a study published today in Biofunctional Materials, Prof. Dr. Haidar, Founder and CEO of BioMAT’X I+D+I LABs in Santiago, Chile, explores a new era in healthcare diagnostics driven by ...

You don't want to miss this! To permanently access this eBook for free, fill out the short form below. Discover practical strategies for syndemic testing of syphilis, HIV, and HCV in this free eBook.

Please provide your email address to receive an email when new articles are posted on . Point-of-care saliva testing can detect HIV in 20 minutes. HIV testing rates jumped from 12% to 55% at a clinic ...

A novel nanobody-based immunosensor, designed to function stably in undiluted biological fluids and harsh conditions, has been developed. Their innovative design leverages BRET -- bioluminescence ...

WASHINGTON--(BUSINESS WIRE)--CorVista Health, Inc., a leading digital health company dedicated to improving cardiovascular disease diagnosis, is pleased to announce the presentation of Machine ...

Credit: Cepheid. The Xpert HCV test delivers results in about an hour. The Food and Drug Administration (FDA) has granted marketing authorization to Xpert ® HCV, a point-of-care hepatitis C virus (HCV ...

LOS ANGELES--(BUSINESS WIRE)--Curative Inc., a leading health services company that recently launched a new health plan out of Texas, announces the spin-off of Sensible Diagnostics, whose aim is to ...

Please provide your email address to receive an email when new articles are posted on . A point-of-care troponin test could reduce time patients with a heart attack spend in the ED by nearly 45 ...

Genetic testing for hereditary cancers, such as breast, colon, pancreatic, and ovarian cancer, helps at-risk individuals understand their familial risk for these diseases and make informed decisions ...